Back
Day Range
$46.40
$47.84
52-Week Range
$30.04
$78.48
Volume
1,441,615
50D / 200D Avg
$53.33
/
$55.91
Prev Close
$46.24
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -7.7 | 0.4 |
| P/B | 2.3 | 2.9 |
| ROE % | -30.2 | 3.7 |
| Net Margin % | -16569.8 | 3.8 |
| Rev Growth 5Y % | -75.1 | 10.0 |
| D/E | 0.2 | 0.2 |
Key Takeaways
Revenue declined -75.10% annually over 5 years
Debt/Equity of 0.21 — conservative balance sheet
Negative free cash flow of -345.93M
Revenue growth is decelerating — 1Y growth trails 5Y average by 14.87%
Growth
Revenue Growth (5Y)
-75.10%
Revenue (1Y)-89.97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-30.18%
ROIC-18.40%
Net Margin-16569.77%
Op. Margin-16191.40%
Safety
Debt / Equity
0.21
Current Ratio13.32
Interest Coverage0.00
Valuation
P/E Ratio
-7.74
P/B Ratio2.34
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -89.97% | Revenue Growth (3Y) | -90.26% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -75.10% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.51M | Net Income (TTM) | -581.60M |
| ROE | -30.18% | ROA | -25.67% |
| Gross Margin | -6537.01% | Operating Margin | -16191.40% |
| Net Margin | -16569.77% | Free Cash Flow (TTM) | -345.93M |
| ROIC | -18.40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.21 | Current Ratio | 13.32 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.74 | P/B Ratio | 2.34 |
| P/S Ratio | 1281.99 | PEG Ratio | -0.17 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 4.50B | Enterprise Value | 4.54B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.51M | 35.00M | 370.00M | 436,000.0 | 913.08M |
| Net Income | -581.60M | -366.25M | -153.61M | -650.18M | 377.66M |
| EPS (Diluted) | -6.47 | -4.34 | -1.94 | -8.36 | 4.70 |
| Gross Profit | -229.45M | -75.25M | 239.75M | -109.81M | 811.90M |
| Operating Income | -568.32M | -466.57M | -222.54M | -673.16M | 373.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.27B | 2.24B | 2.23B | 2.24B | 2.75B |
| Total Liabilities | 343.43M | 309.95M | 346.77M | 367.58M | 352.42M |
| Shareholders' Equity | 1.92B | 1.93B | 1.88B | 1.88B | 2.40B |
| Total Debt | 394.91M | 223.69M | 238.63M | 244.02M | 225.03M |
| Cash & Equivalents | 355.19M | 298.26M | 389.48M | 211.89M | 923.03M |
| Current Assets | 1.99B | 1.94B | 1.91B | 1.85B | 2.42B |
| Current Liabilities | 149.12M | 87.78M | 108.79M | 121.11M | 119.88M |